Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 2 hours ago
Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
about 2 hours ago
With an FDA decision date looming for its Duchenne muscular dystrophy (DMD)...
Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
about 2 hours ago
Gilead raised its previous guidance of $800 million in revenues from the...
Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
about 2 hours ago
Daiichi Sankyo is poised to report significantly lower full-year profit for fiscal...
AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard
about 3 hours ago
After losing the top spot in March to Johnson & Johnson’s immunology...
Johnson & Johnson launches ‘Generation Fine’ depression project
about 4 hours ago
You’ve heard of Gen Z, but now Johnson & Johnson wants you...
Revisiting Pharma’s tariff reality
about 4 hours ago
Fierce Pharma’s Fraiser Kansteiner catches up with KPMG’s Chris Young to discuss...
Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
about 5 hours ago
Summit's PD-1xVEGF study surprisingly missed its mark at an interim analysis. UCB...
GSK tees up a Modern Family for meningitis messaging
about 5 hours ago
GSK is teaming up with “Modern Family” stars Julie Bowen and Ty...
Pre-launch efforts linked to lasting drug awareness edge: report
about 8 hours ago
Cancer treatments with high levels of physician awareness at launch maintain their...
How many of these 7 ADC handling considerations are on your radar?
about 20 hours ago
From cytotoxic safety to cold chain control, ADC manufacturing faces new pressures...
Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
1 day ago
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma has...
The timing is right for psychedelics manufacturer Optimi Health's IPO
1 day ago
Last month, when Optimi Health kicked off an initial public offering of...